SCHEMBL6168680

SCHEMBL6168680

O=C(c1ccccc1)c1cc2c(Cl)c(Cl)ccc2[nH]1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
HRH4 Q9H3N8 1/20 0.51
ALOX15 P16050 2/20 0.50
HTR6 P50406 1/20 0.49
HDAC6 Q9UBN7 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
TSHR P16473 1/20 0.48
FLT3 P36888 3/20 0.46
RHEB Q15382 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
HSD17B10 Q99714 1/20 0.44
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168641 0.83 FLT3 (0.60) MEN1KMT2ANPC1RAB9AHRH4
SCHEMBL708527 0.82 GRIN1 (0.57) MEN1KMT2AHRH4ALOX15CYP1A2
SCHEMBL6168465 0.79 GRIN1 (0.67) MEN1KMT2ANPC1RAB9AALOX15
SCHEMBL12428146 0.77 HSD17B10 (0.74) MEN1KMT2ANPC1RAB9AHTR6
SCHEMBL6170489 0.75 MEN1 (0.70) MEN1KMT2ANPC1RAB9AALOX15
SCHEMBL24754486 0.74 HRH4 (0.56) KMT2ANPC1HRH4ALOX15FLT3
SCHEMBL19331400 0.74 HRH4 (0.56) NPC1RAB9AHRH4CYP1A2FLT3
SCHEMBL30039640 0.74 HRH4 (0.56) NPC1RAB9AHRH4CYP1A2FLT3
SCHEMBL11002795 0.74 MEN1 (0.55) MEN1KMT2ANPC1RAB9AALOX15
SCHEMBL29399564 0.71 MEN1 (0.47) MEN1KMT2ANPC1RAB9AHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed